Nifty500 Multifactor MQVLv 50

HDFC Asset Management Company has enclosed transcript of Earnings Call for the quarter and half year ended September 30, 2026, conducted after the meeting of the Board of Directors on October 15, 2026 which can also be accessed on the website of the Company at: https://www.hdfcfund.com/about-us/financialinformation/shareholder-presentation

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences has informed that it enclosed a copy of press release dated October 21, 2026, titled ‘Zydus receives USFDA approval for Estradiol and Levonorgestrel Transdermal System, eligible for 180-day CGT exclusivity’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, State Bank of India has informed that the Bank has experienced an incident involving the loss of certain data. On 16 October 2026, the Bank received communications from its Threat Intelligence Service Provider, the Defence Cyber Agency, and CERT-In regarding an alert concerning the suspected exposure of the Bank’s customer data on the dark web. During the preliminary analysis of approximately 375,000 records available on the dark web, 3,897 customer records containing Personally Identifiable Information (PII) were identified. The exposed information reportedly included customers’ registered mobile numbers, dates of birth, names, gender, email addresses, residential addresses, branch and CIF identifiers, lead IDs, and metadata associated with loan/lead records and other related files. A detailed investigation was required to establish the authenticity and completeness of the exposed data, determine the potential source and extent of the exposure, and assess the associated risks to customers and the Bank. The Bank promptly activated its cyber incident response and containment protocols. Additionally, an independent CERT-In-empanelled cybersecurity agency was engaged to conduct a comprehensive assessment and investigate the nature and extent of the alleged compromise. The company has informed that this does not have any material impact on Bank’s Core business operations, financial performance or business continuity. The Bank’s core business functions continue to operate normally without disruptions. A detailed assessment is currently underway and appropriate remedial and preventive measures are being implemented as required. The company has reassured that the Bank continues to monitor the situation closely and take all appropriate measures in accordance with applicable regulatory requirements.

The above information is a part of company’s filings submitted to BSE.

Pursuant to the provisions of regulation 29(1) of the Listing Regulations, Zydus Lifesciences has informed that the meeting of the Board of Directors of Zydus Lifesciences will be held on Wednesday, November 4, 2026, to consider, apart from other agenda items, approval of unaudited financial results for the quarter / half year ended on September 30, 2026. The trading window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed till Friday, November 6, 2026, and shall open for trading on and from Monday, November 9, 2026, for all the Directors and Designated Persons of the Company.

The above information is a part of company’s filings submitted to BSE.

Tata Consultancy Services has informed that it enclosed copy of the Press Release titled ‘TCS BaNCS for Treasury marks its entry into Sri Lanka with Indian Bank’.

The above information is a part of company’s filings submitted to BSE.